IBRX - Immunitybio - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IBRX is currently covered by 5 analysts with an average price target of $7.34. This is a potential upside of $5.23 (247.87%) from yesterday's end of day stock price of $2.11.

Immunitybio's activity chart (see below) currently has 33 price targets and 34 ratings on display. The stock rating distribution of IBRX is 8.33% HOLD and 91.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.61% with an average time for these price targets to be met of 314 days.

Highest price target for IBRX is $24, Lowest price target is $5, average price target is $12.33.

Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 13-Nov-2025. First documented stock forecast 24-Aug-2015.

Best performing analysts who are covering IBRX - Immunitybio:

Biren Amin Kelly Shi Joseph Catanzaro Joel Beatty Jason Kolbert Andrew Fein

Currently out of the existing stock ratings of IBRX, 1 are a HOLD (8.33%), 11 are a BUY (91.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$24

$21.64 (916.95%)

1 months 4 days ago
(13-Nov-2025)

0/1 (0%)

$22 (1100.00%)

Buy

$5

$2.64 (111.86%)

$4.25

6 months 27 days ago
(20-May-2025)

5/12 (41.67%)

$2.1 (72.41%)

103

Buy

$8

$5.64 (238.98%)

$8

7 months 19 days ago
(28-Apr-2025)

0/2 (0%)

$5.37 (204.18%)

Buy

$5

$2.64 (111.86%)

$8

2 years 7 months 2 days ago
(15-May-2023)

2/2 (100%)

$1.78 (55.28%)

431

Sell

$0.8

$-1.56 (-66.10%)

$1.25

6 years 6 months 16 days ago
(31-May-2019)

4/5 (80%)

$-0.23 (-22.33%)

277

Show more analysts

Please expand the browser size to see the chart

What is IBRX (Immunitybio) average time for price targets to be met?

On average it took 314 days on average for the stock forecasts to be realized with a an average price target met ratio 53.61

Which analyst has the current highest performing score on IBRX (Immunitybio) with a proven track record?

BIREN AMIN

Which analyst has the current lower performing score on IBRX (Immunitybio) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on IBRX (Immunitybio)?

Biren Amin works at PIPER SANDLER and has 5 price targets and 6 ratings on IBRX

Which analyst is the currently most bullish on IBRX (Immunitybio)?

Jason Kolbert with highest potential upside - $21.64

Which analyst is the currently most reserved on IBRX (Immunitybio)?

Joel Beatty with lowest potential downside - -$1.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?